相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells
Craig S. Schneider et al.
BIOMATERIALS (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
Evan M. Cherry et al.
MOLECULAR CANCER (2015)
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
Sang-Soo Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Polymeric drug delivery for the treatment of glioblastoma
Scott D. Wait et al.
NEURO-ONCOLOGY (2015)
Advances in Anticancer Immunotoxin Therapy
Christine Alewine et al.
ONCOLOGIST (2015)
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Cancer nanomedicine: from targeted delivery to combination therapy
Xiaoyang Xu et al.
TRENDS IN MOLECULAR MEDICINE (2015)
APhase I Monotherapy Study of RG7212, a First-in-Class Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Cancers
Ulrik N. Lassen et al.
CLINICAL CANCER RESEARCH (2015)
The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion
Emily Cheng et al.
MOLECULAR CANCER RESEARCH (2015)
Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration
Elizabeth Nance et al.
ACS NANO (2014)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system
Muna Aryal et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Glioblastoma: From Molecular Pathology to Targeted Treatment
Timothy F. Cloughesy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Fibroblast growth factor-inducible 14 regulates cell growth and multidrug resistance of small-cell lung cancer through the nuclear factor-κB pathway
Xiaoping Li et al.
ANTI-CANCER DRUGS (2014)
AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
JuanJuan Yin et al.
CANCER RESEARCH (2014)
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioblastoma cell chemotaxis via Lyn activation
Harshil D. Dhruv et al.
CARCINOGENESIS (2014)
Targeted anticancer therapy: Overexpressed receptors and nanotechnology
Mohd Javed Akhtar et al.
CLINICA CHIMICA ACTA (2014)
FN14 expression correlates with MET in NSCLC and promotes MET-driven cell invasion
Timothy G. Whitsett et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Regulation of Fibroblast Growth Factor-inducible 14 ( Fn14) Expression Levels via Ligand-independent Lysosomal Degradation
Sujatha Gurunathan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Analysis of Biodistribution of Intracranially Infused Radio labeled Interleukin-13 Receptor-Targeted Immunotoxin IL-13PE by SPECT/CT in an Orthotopic Mouse Model of Human Glioma
Akiko Suzuki et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Development of HumanSerine Protease-Based Therapeutics Targeting Fn14 and Identification of Fn14 as a New Target Overexpressed in TNBC
Hong Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment
Guifa Xi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Nanotherapeutic approaches for brain cancer management
Laura Saenz del Burgo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: Potential for targeting experimental brain tumors
Roberto Jose Diaz et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma
Giovanna M. Bernal et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery
Vladimir P. Torchilin
NATURE REVIEWS DRUG DISCOVERY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Targeting adaptive glioblastoma: an overview of proliferation and invasion
Qian Xie et al.
NEURO-ONCOLOGY (2014)
Intracranial Applications of Magnetic Resonance-guided Focused Ultrasound
Nir Lipsman et al.
NEUROTHERAPEUTICS (2014)
Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts
Ludmilla de Plater et al.
PLOS ONE (2014)
In vivo radiation response of proneural glioma characterized by protective p53 transcriptional program and proneural-mesenchymal shift
John Halliday et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma
Brian J. Gill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
TWEAK/Fn14 axis: The current paradigm of tissue injury-inducible function in the midst of complexities
Linda C. Burkly
SEMINARS IN IMMUNOLOGY (2014)
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
James P. Sullivan et al.
CANCER DISCOVERY (2014)
TWEAK/Fn14 axis: a promising target for the treatment of cardiovascular diseases
Luis M. Blanco-Colio
FRONTIERS IN IMMUNOLOGY (2014)
Emerging insights into barriers to effective brain tumor therapeutics
Graeme E. Woodworth et al.
FRONTIERS IN ONCOLOGY (2014)
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
Roy van der Meel et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Glioblastoma: Molecular Analysis and Clinical Implications
Jason T. Huse et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
The TWEAK-Fn14 system as a potential drug target
Harald Wajant
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors
Hong Zhou et al.
CANCER RESEARCH (2013)
Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology
Uma Prabhakar et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Construction of an Immunotoxin, D2C7-(scdsFv)-PE38KDEL, Targeting EGFRwt and EGFRvIII for Brain Tumor Therapy
Vidyalakshmi Chandramohan et al.
CLINICAL CANCER RESEARCH (2013)
RG7212 Anti-TWEAK mAb Inhibits Tumor Growth through Inhibition of Tumor Cell Proliferation and Survival Signaling and by Enhancing the Host Antitumor Immune Response
Xuefeng Yin et al.
CLINICAL CANCER RESEARCH (2013)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-TWEAK Monoclonal Antibody in Patients With Rheumatoid Arthritis
Nicolas Wisniacki et al.
CLINICAL THERAPEUTICS (2013)
Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
Vidyalakshmi Chandramohan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Structural Basis and Targeting of the Interaction between Fibroblast Growth Factor-inducible 14 and Tumor Necrosis Factor-like Weak Inducer of Apoptosis
Harshil Dhruv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
Steffen Salzmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The Src Homology 3 Domain-containing Guanine Nucleotide Exchange Factor Is Overexpressed in High-grade Gliomas and Promotes Tumor Necrosis Factor-like Weak Inducer of Apoptosis-Fibroblast Growth Factor-inducible 14-induced Cell Migration and Invasion via Tumor Necrosis Factor Receptor-associated Factor 2
Shannon P. Fortin Ensign et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
Debra T. Chao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment
Hong Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Diphtheria toxin-based targeted toxin therapy for brain tumors
Yan Michael Li et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Strategies for advancing cancer nanomedicine
Vikash P. Chauhan et al.
NATURE MATERIALS (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention
Liying Gu et al.
PLOS ONE (2013)
TWEAK-Independent Fn14 Self-Association and NF-κB Activation Is Mediated by the C-Terminal Region of the Fn14 Cytoplasmic Domain
Sharron A. N. Brown et al.
PLOS ONE (2013)
Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells
Harshil D. Dhruv et al.
PLOS ONE (2013)
BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis
Vassiliki Pelekanou et al.
PLOS ONE (2013)
Current status of local therapy in malignant gliomas - A clinical review of three selected approaches
Tareq A. Juratli et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Patient-Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ
Kyeung Min Joo et al.
CELL REPORTS (2013)
Function of the Blood-Brain Barrier and Restriction of Drug Delivery to Invasive Glioma Cells: Findings in an Orthotopic Rat Xenograft Model of Glioma
Sagar Agarwal et al.
DRUG METABOLISM AND DISPOSITION (2013)
Therapeutic nanomedicine for brain cancer
Stephany Y. Tzeng et al.
THERAPEUTIC DELIVERY (2013)
Elevated Expression of Fn14 in Non-Small Cell Lung Cancer Correlates with Activated EGFR and Promotes Tumor Cell Migration and Invasion
Timothy G. Whitsett et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Prognostic Significance of TWEAK Expression in Colorectal Cancer and Effect of Its Inhibition on Invasion
Been-Ren Lin et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Toxin-Based Targeted Therapy for Malignant Brain Tumors
Vidyalakshmi Chandramohan et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
ALKBH3 Contributes to Survival and Angiogenesis of Human Urothelial Carcinoma Cells through NADPH Oxidase and Tweak/Fn14/VEGF Signals
Keiji Shimada et al.
CLINICAL CANCER RESEARCH (2012)
Drug delivery strategies for the treatment of malignant gliomas
Daniela Allhenn et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases; focus on inflammatory bowel diseases
Taeko Dohi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Ultrasound-assisted convection-enhanced delivery to the brain in vivo with a novel transducer cannula assembly Laboratory investigation
George K. Lewis et al.
JOURNAL OF NEUROSURGERY (2012)
The disturbed blood-brain barrier in human glioblastoma
Hartwig Wolburg et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Cdc42 and the Guanine Nucleotide Exchange Factors Ect2 and Trio Mediate Fn14-Induced Migration and Invasion of Glioblastoma Cells
Shannon P. Fortin et al.
MOLECULAR CANCER RESEARCH (2012)
'Go or Grow': the key to the emergence of invasion in tumour progression?
H. Hatzikirou et al.
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2012)
Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells
Ana Belen Sanz et al.
PLOS ONE (2012)
Cellular Inhibitors of Apoptosis Are Global Regulators of NF-κB and MAPK Activation by Members of the TNF Family of Receptors
Eugene Varfolomeev et al.
SCIENCE SIGNALING (2012)
A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
Elizabeth A. Nance et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Enhanced Intracellular Delivery and Chemotherapy for Glioma Rats by Transferrin-Conjugated Biodegradable Polymersomes Loaded with Doxorubicin
Zhiqing Pang et al.
BIOCONJUGATE CHEMISTRY (2011)
Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
Mingguo Huang et al.
CARCINOGENESIS (2011)
TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses
Linda C. Burkly et al.
IMMUNOLOGICAL REVIEWS (2011)
Affinity-matured anti-glycoprotein NMB recombinant immunotoxins targeting malignant gliomas and melanomas
Chien-Tsun Kuan et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE study
Sabine Mueller et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Development and Characterization of a Potent Immunoconjugate Targeting the Fn14 Receptor on Solid Tumor Cells
Hong Zhou et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Development of an Fn14 agonistic antibody as an anti-tumor agent
Jennifer S. Michaelson et al.
MABS (2011)
Colocalization of Gadolinium-Diethylene Triamine Pentaacetic Acid With High-Molecular-Weight Molecules After Intracerebral Convection-Enhanced Delivery in Humans
John H. Sampson et al.
NEUROSURGERY (2011)
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma
Lilach Agemy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies
Vikash P. Chauhan et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 2 (2011)
The Pathobiology of Glioma Tumors
Candece L. Gladson et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
EGFRvIII Antibody-Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging-Guided Convection-Enhanced Delivery and Targeted Therapy of Glioblastoma
Costas G. Hadjipanayis et al.
CANCER RESEARCH (2010)
Antibodies to TWEAK Receptor Inhibit Human Tumor Growth through Dual Mechanisms
Patricia A. Culp et al.
CLINICAL CANCER RESEARCH (2010)
Full-length, Membrane-anchored TWEAK Can Function as a Juxtacrine Signaling Molecule and Activate the NF-κB Pathway
Sharron A. N. Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF-κB Pathway
Claudia Roos et al.
JOURNAL OF IMMUNOLOGY (2010)
Poor drug distribution as a possible explanation for the results of the PRECISE trial Clinical article
John H. Sampson et al.
JOURNAL OF NEUROSURGERY (2010)
Effect of Pazopanib on Tumor Microenvironment and Liposome Delivery
Tina D. Tailor et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma
Sandeep Kunwar et al.
NEURO-ONCOLOGY (2010)
Small-molecule delivery by nanoparticles for anticancer therapy
Zhuo (Georgia) Chen
TRENDS IN MOLECULAR MEDICINE (2010)
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
Emilie Allard et al.
BIOMATERIALS (2009)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Unsupervised Analysis of Transcriptomic Profiles Reveals Six Glioma Subtypes
Aiguo Li et al.
CANCER RESEARCH (2009)
Using gene expression profiling to identify a prognostic molecular spectrum in gliomas
Mitsuaki Shirahata et al.
CANCER SCIENCE (2009)
Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Stimulation of Glioma Cell Survival Is Dependent on Akt2 Function
Shannon P. Fortin et al.
MOLECULAR CANCER RESEARCH (2009)
Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model
Achuthamangalam B. Madhankumar et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Modeling Adult Gliomas Using RCAS/t-va Technology
Dolores Hambardzumyan et al.
TRANSLATIONAL ONCOLOGY (2009)
The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity
Amanda L. Willis et al.
MOLECULAR CANCER RESEARCH (2008)
Targeting IL-13Rα2-positive cancer with a novel recombinant immunotoxin composed of a single-chain antibody and mutated Pseudomonas exotoxin
Mitomu Kioi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
The TWEAK - Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting
Jeffrey A. Winkles
NATURE REVIEWS DRUG DISCOVERY (2008)
Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors
John H. Sampson et al.
NEURO-ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diffusion in brain extracellular space
Eva Sykova et al.
PHYSIOLOGICAL REVIEWS (2008)
Gene expression-based molecular diagnostic system for malignant gliomas is superior to histological diagnosis
Mitsuaki Shirahata et al.
CLINICAL CANCER RESEARCH (2007)
A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor-expressing tumor cells
Jill Wykosky et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma
George S. Watts et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Expression of interleukin-13 receptor α2 in glioblastoma multiforme:: Implications for targeted therapies
John S. Jarboe et al.
CANCER RESEARCH (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: A report by the Cintredekin Besudotox Intraparenchymal Study Group
Sandeep Kunwar et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: Descriptive effects of target anatomy and catheter positioning
John H. Sampson et al.
NEUROSURGERY (2007)
Molecular targets of glioma invasion
M. Nakada et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice
Edward Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Role of TWEAK and Fn14 in tumor biology
Jeffrey A. Winkles et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration
Mahasweta Girgenrath et al.
EMBO JOURNAL (2006)
Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-κB and correlate with poor patient outcome
Nhan L. Tran et al.
CANCER RESEARCH (2006)
Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient
E Rustamzadeh et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to Pseudomonas exotoxin
Gregory J. A. Murad et al.
CLINICAL CANCER RESEARCH (2006)
TWEAK and Fn14: New molecular targets for cancer therapy?
JA Winkles et al.
CANCER LETTERS (2006)
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space
RG Thorne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis
S Desplat-Jégo et al.
CLINICAL IMMUNOLOGY (2005)
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme
C Giannini et al.
NEURO-ONCOLOGY (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFκB pathway activation and BCL-XL/BCL-W expression
NL Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Soluble tumor necrosis factor-like weak inducer of apoptosis overexpression in HEK293 cells promotes tumor growth and angiogenesis in athymic nude mice
DH Ho et al.
CANCER RESEARCH (2004)
Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis
T Kawakita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
AC Bellail et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas
M Weaver et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Cost of migration: Invasion of malignant gliomas and implications for treatment
A Giese et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Diffusion parameters of the extracellular space in human gliomas
L Vargová et al.
GLIA (2003)
The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors
NL Tran et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis
SR Wiley et al.
IMMUNITY (2001)
Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis
L Mariani et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas
SLY Feng et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
